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Juvenile cystic kidneys (jck): A new mouse mutation which causes
polycystic kidneys. We have characterized a new recessive mutation in
the mouse which predisposes to the development of polycystic kidney
disease. This mutation, called juvenile cystic kidneys (jck), arose in a
transgenic line of mice, but appears unrelated to the transgene since it
segregates freely from it. While focal cysts are evident in affected
animals as early as three days of life and the disease is progressive, the
mice are fertile and generally survive to four or more months of age.
Complementation analysis indicates that the jck mutation is not allelic
with three other known recessive polycystic kidney mutations (cpk and
two as yet unnamed mutations), and linkage studies demonstrate it is
unlikely to be allelic with a fourth (pcy). The study of these five
mutations and their interactions should prove useful for understanding
the mechanisms required to maintain the normal integrity of renal
tubules.
The development of polycystic kidney disease is a feature of
a variety of human heritable disorders. The most well studied of
these is autosomal-dominant polycystic kidney disease
(ADPKD). This disorder is relatively common, with an esti-
mated prevalence of about 1 in 1000 [1]. Symptoms related to
renal dysfunction are usually detected in early adulthood,
although the age of onset can vary widely. In addition to renal
abnormalities, ADPKD is frequently associated with cystic
liver disease, and occasionally splenic and pancreatic abnor-
malities. Aneurysms of cerebral arteries are also a feature of
ADPKD [21. The etiology of this disease is as yet unknown, and
theories have been proposed which suggest the possible contri-
bution of aberrant epithelial hyperplasia [31 or defects in the
extracellular matrix [4].
Even less is known about recessively inherited disorders that
predispose to the development of polycystic kidney disease
(ARPKD). Potter noted the familial occurrence of polycystic
kidneys in infants [5], and Lundin and Olow proposed the
existence of a recessive form of heritable polycystic kidney
disease [6]. This was confirmed by the family studies of Blyth
and Ockenden [7]. They also documented that the age of onset
of ARPKD, while clearly much earlier than ADPKD, can still
be quite variable. The presentation can range from a neonate
with the classic oligohydramnios sequence (Potter's facies,
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pulmonary hypoplasia, and joint contractures) to infants with
oliguria or anuria to older children who have symptoms relating
primarily to hepatic fibrosis, especially portal hypertension.
The etiology of ARPKD is not known. Microdissection, lectin-
binding, and immunohistochemical studies suggest that the
cysts in ARPKD arise in the distal nephron [8].
In the mouse, a number of recessive mutations have been
discovered which predispose to the development of polycystic
kidneys. The cpk (congenital polycystic kidneys) mutation was
the first mouse model of ARPKD to be identified. These mice
have a rapidly progressive disorder that is evident by 10 to 13
days of age and is fatal by 20 to 25 days of age [9]. The mutation
has been studied by linkage analysis using Robertsonian trans-
locations and recombinant inbred (RI) strains, and has been
mapped to the proximal region of mouse Chromosome 12 [10].
A different mutation, called pcy (polycystic kidneys), was
discovered in a KK mouse and has been transferred to the
DBAI2J and C57BL/6J backgrounds [11]. In contrast to cpk,
these mice develop overt polycystic kidney disease consider-
ably later in life. The pcy mutation has also been analyzed by
linkage studies and has been found to map distal to the
transferrin gene on mouse Chromosome 9 [12]. Two additional
recessive mutations, as yet unnamed, have recently been dis-
covered at the Jackson Laboratory. These have a similar
phenotype as cpk, but complementation studies suggest that
they are not allelic (nor are they allelic to each other) (M. T.
Davisson, personal communication). Neither has been chromo-
somally mapped. Finally, as described below, we have discov-
ered a new mutation with an intermediate phenotype called jck,
for juvenile cystic kidneys. This mutation does not appear to be
allelic with any of the previously described mutants.
Methods
Mice
The jck mutation arose in a transgenic line, originally called
l47-9a, which carries an insertional mutation at the perinatal
lethality (pie) locus on Chromosome 15 [13]. The transgene is a
MMTV/c-myc chimeric gene [14]. The transgene segregates
independently from thejck mutation and has been crossed away
from the present stock used to maintain the line. The jck
mutation is presently being inbred into C57BLI6J by serial
backcross. C57BL/6J cpkl+ mice used were maintained at
Harvard and mice carrying each of the two new mutants were
provided by Dr. M. T. Davisson (The Jackson Laboratory, Bar
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+1+ Xjc/c/jck 18 18 0
jck/+ xjck/+ 67 53 14
jck/+ Xjck/+ 62 46 16
The results of three crosses are shown. In the first cross affected jck
mice (both male and female) were mated with wild-type C57BL/6J mice.
In the second cross their progeny, which were presumptive heterozy-
gotes, were mated together. The third experiment is another cross
between presumptive heterozygotes found by test matings. All results
are consistent with a recessive mode of inheritance for the jck mutation.
Abbreviations are: +, wild-type; pk, polycystic kidneys.
Harbor, Maine, USA). Crosses were performed as described in
the Table legends.
Histology
Tissues processed for light microscopy were fixed in 10%
buffered formalin, pH 7.2, and embedded in glycol methylacry-
late as previously described [9]. Sections were cut at four
micrometers and stained with hematoxylin and eosin.
Enzyme analysis
Serum samples were obtained with the cardiac puncture
technique. The creatinine concentration of serum from affected
mice and age-matched controls were determined by a standard
assay.
Results
The jck (juvenile cystic kidneys) mutation arose in a trans-
genie line of mice which is being studied because mice that are
homozygous for the transgene have a presumptive insertional
mutation that results in perinatal death [13]. The insertion site
of the transgene has been cloned and is presently being ana-
lyzed to detect the disrupted gene (D.B., unpublished results).
In the process of intercross analysis of this transgenic line, it
was noted that mice in several related sibships were dying at
about four to six months of age. Several of these mice were
found upon autopsy to have grossly enlarged spongy-appearing
kidney; histology revealed these to be polycystic. The possibil-
ity that this apparent polycystic kidney disease was due to a
recessive mutation was tested by crossing mice related to these
affected animals. Progeny with the polycystic kidney phenotype
were recovered in several independent matings of these poten-
tial carriers. Analysis of the inheritance of the transgene in
these crosses revealed that it segregated randomly with respect
to the polycystic kidney phenotype (data not shown). The
transgene has now been crossed out of the stock used to
maintain thejck mutation; this has not affected the incidence or
course of polycystic kidney disease.
Additional crosses were done to confirm that the jck mutation
is a recessive trait. As shown in Table 1, progeny of crosses
between affected (homozygous) mice and wild-type mice are
not affected. When these progeny, which are presumptive
heterozygotes, are intercrossed, one quarter of their offspring
are affected, consistent with recessive inheritance. The back-
ground on which the jck mutation arose was not completely
Table 2. Linkage analysis with dilute
Phenotype
Cross N ++ jck + +d jck d
jcki+ +id x jcki+ +id 78 39 (44) 13 (15) 21(15) 5 (5)
Homozygous jck males were mated with DBA/2J females which are
homozygous at dilute (d). Fl progeny are obligate double heterozy-
gotes. These were intercrossed and their offspring scored for the
polycystic kidney and dilute coat color phenotypes at 7 weeks of age.
The expected numbers of progeny in each class if jck and d segregate
randomly are shown in parentheses. Abbreviations are: +, wild type;
jck,jckijck, d, did.
inbred, but is most closely related to CS7BL16J. The mutation is
being further bred into this background by serial backcrosses.
Since several mutations exist in the mouse which predispose
to polycystic kidney disease, it was possible that jck was a new
mutation at a previously identified locus. This was tested by
complementation analysis. The jck mutation was analyzed by
crossing proven heterozygous jckl+ mice with mice proved to
be heterozygous for cpk or one of the new mutations from The
Jackson Laboratory. Mice were scored for the polycystic
kidney phenotype at two months of age, which is well past the
onset of overt disease in all of these mutant lines. No affected
offspring were detected in any of the three crosses (N = 19 for
the cpk cross; N = 25 and 22 in crosses with the new unnamed
mutations). The analysis of this number of progeny is sufficient
such that the absence of affected animals is statistically signif-
icant (P < 0.01), which supports the conclusion that jck is not
allelic with any of these three mutations.
Allelism with the pcy mutation was tested indirectly by
mapping jck with respect to the dilute (d) locus. The pcy
mutation has been found to map 16.5 4.2 CM distal to this coat
color marker [12]. In progeny of an intercross between doubly
heterozygousjck/+ dI+ mice, no linkage between jck and d was
found (Table 2), suggesting that these mutations are not alleles
of the same gene.
The course of polycystic disease in the jck mice is consistent.
Enlarged kidneys cannot usually be palpated prior to four to
five weeks of age, and are invariably detectable in affected mice
by seven weeks. Affected mice generally survive at least 20, but
not longer than 25, weeks, and generally appear quite active
until shortly before death. Both male and female affected mice
are fertile, although the females do not consistently care for
their litters. Fertility in affected male mice appears to decrease
after about 15 weeks. However, it is practical to maintain the
production of a large number of affected mice by crossing
homozygous males with heterozygous females.
For the histological analysis of thejck mutation, organs from
affected 30, 50, 75, and 100 day-old mice were fixed, sectioned,
and examined by light microscopy. To assess the effect of jck in
mice prior to overt kidney enlargement, litters from obligate
heterozygote mice were sacrificed and analyzed. In several
three-day-old progeny of such crosses, kidneys with small
isolated cysts lined by cuboidal epithelial cells were observed.
By 15 days, cysts lined by flattened epithelia were evident and
about 15% of the kidney cortex was affected. Progressive cystic
changes were found with increasing age, with predominantly
cortical disease, followed by outer medullary involvement (Fig.
1). No histologic abnormalities were found in any other organs
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Fig. 1. Photomicrographs of hematoxylin and eosin-stained tissue sections from jck mice. A-D: Affected kidneys at 3, 15, 50 and 100 days after
birth, respectively. Cysts lined by flattened epithelia are evident at 3 days and cystic changes proceed progressively thereafter. By day 50 most
of the kidney is involved. Original magnification = 40x.
(although cerebral vasculature was not examined); specifically,
no hepatic, splenic, or pancreatic cysts or fibrosis was detected.
The serum creatinine of affected mice was measured and was
found to increase linearly with age (Fig. 2). Creatinine levels
ranged between 0.3 mg/dl in 40-day-old mice to 1.0 mg/dl in
120-day-old mice (normal value is <0,12 mgldl).
Discussion
We have identified a new recessive mutation in the mouse
which predisposes to the development of polycystic kidney
disease. This mutation has a phenotype that is unlike previously
described mutations, with the onset of overt disease at four to
five weeks of age. Complementation analysis demonstrated that
jck is not allelic with three known polycystic kidney mutations.
Additionally, mapping of the jck mutation with respect to the
dilute (d) locus suggests that it is not an allele of pcy. While the
jck mutation arose in a transgenic line, it does not appear to be
direcfly caused by the transgene, since the mutation segregates
freely from it.
There are at least five independent loci in the mouse that, if
mutated, predispose to the development of ARPKD. The renal
abnormalities of another mutant, originally called ,jpk, for
juvenile polycystic kidneys, have been shown to be, in fact, a
consequence of congenital hydronephrosis. This mutation has
been renamed cph (congenital progressive hydroncphrosis) and
has been mapped to distal mouse Chromosome 15 [15]. The
characterization of the mutations at the multiple loci which are
associated with polycystic kidney disease should provide in-
sight into genes required for normal renal physiology and
potentially their interactions with each other as well.
The abnormalities in these mutant mice appear in many
respects to be similar to those found in human polycystic
kidney disease, and they are presently being used for in vitro
studies of the biology of cystic kidneys [16, 17]. Pre- and
postnatal light and electron microscopic studies suggest that in
the earliest stages of this abnormality pathologic changes occur
in the intercellular tight junctions of the proximal tubules.
However, hepatic abnormalities, which are a constant feature
in human polycystic disease, are found only infrequently in the
most severe mouse mutant (cpk) and not at all in the other
mutant lines, including jck. While this may be taken as evidence
that these mutations are unrelated to the polycystic disease in
humans, it is perhaps more plausible that this discordance in
phenotype is a consequence of the different physiology of
rodents and humans. Interestingly, when the cpk gene was
transferred to the DBAI2 background, pancreatic and liver
abnormalities were seen [9].
The genetics of human autosomal-dominant PKD has re-
cently been the focus of extensive molecular analysis. It has
been clearly shown that the inheritance of the trait in many
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tionship of genes within large sub-chromosomal regions has
been conserved during mammalian evolution, localization of a
trait in the mouse can suggest a likely map position of its human
homolog. This can facilitate a more focused analysis of linkage
in affected ARPKD kindreds to these regions, as opposed to the
undirected screening of random genomic markers. Further-
more, genetic mapping of these mouse mutations may serve to
identify candidate loci responsible for the polycystic kidney
phenotype; these can be directly tested for abnormalities in
individuals affected with ARPKD.
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